JP Morgan Chase
CRTX

JP Morgan Chase’s CORNERSTONE THERAPEUTICS INC CRTX Stock Holding History

JP Morgan Chase’s Portfolio CRTX Stock Details CRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-120,475
Closed -$1.14M – 4214
2013
Q4 		$1.14M Sell
120,475
-30,130
-20% -$285K ﹤0.01% 3084
2013
Q3 		$1.42M Buy
150,605
+19,307
+15% +$174K ﹤0.01% 3041
2013
Q2 		$1.05M Buy
+131,298
New +$1.11M ﹤0.01% 3227

Other funds holding CRTX

AA
Ancora Advisors Cleveland, Ohio $5.19B AUM 23.19% 1-Year Est. Return

JP Morgan Chase's CRTX Position: Q1 2014 in Review

JP Morgan Chase sold out of CORNERSTONE THERAPEUTICS INC (CRTX) in Q1 2014, closing a stake of 120,475 shares — an estimated $1.14M sold.

JP Morgan Chase first reported a position in CRTX in Q2 2013 and held it in 3 quarters. The position peaked at $1.42M in Q3 2013. 1 fund tracked by Wall St. Rank holds CRTX as of Q1 2014.

  • JP Morgan Chase reported no remaining CORNERSTONE THERAPEUTICS INC position as of Q1 2014 after selling out during the quarter.
  • JP Morgan Chase sold 120,475 CORNERSTONE THERAPEUTICS INC shares in Q1 2014, an estimated $1.14M.
  • JP Morgan Chase first reported a position in CORNERSTONE THERAPEUTICS INC in Q2 2013 and held it in 3 quarters.
  • JP Morgan Chase's CORNERSTONE THERAPEUTICS INC position peaked at $1.42M in Q3 2013.
  • 1 fund tracked by Wall St. Rank held CORNERSTONE THERAPEUTICS INC as of Q1 2014.

Based on JP Morgan Chase's 13F filing for Q1 2014, filed 15 May 2014.